Last 5,570 KRW
Change Today +40.00 / 0.72%
Volume 8.2K
As of 1:13 AM 12/26/14 All times are local (Market data is delayed by at least 15 minutes).

samil pharmaceutical co ltd (000520) Snapshot

Open
5,600
Previous Close
5,530
Day High
5,640
Day Low
5,540
52 Week High
07/25/14 - 6,750
52 Week Low
11/28/14 - 5,290
Market Cap
30.6B
Average Volume 10 Days
3.8K
EPS TTM
205.00
Shares Outstanding
5.5M
EX-Date
12/27/13
P/E TM
27.2x
Dividend
150.00
Dividend Yield
2.69%
Current Stock Chart for SAMIL PHARMACEUTICAL CO LTD (000520)

Related News

No related news articles were found.

samil pharmaceutical co ltd (000520) Related Businessweek News

No Related Businessweek News Found

samil pharmaceutical co ltd (000520) Details

Samil Pharmaceutical Co., Ltd. produces and supplies indispensable medicines for various diseases primarily in South Korea. It offers fever remedies, common cold medicines, eye-related medicines, and devices and medicines for dentistry, as well as hormone replacement therapy. The company also offers CNS drugs, ophthalmic drugs, respiratory drugs, genito-urinary drugs, antibiotics in chemotherapeutics, circulatory drugs, gastro-intestinal drugs, agents for diabetes mellitus, disinfectants, and amino acids, as well as antipyretic, analgesic, anti inflammatory, antihistamine, allergy, hormone, Et cetera, and metabolic drugs. Samil Pharmaceutical Co., Ltd. was founded in 1947 and is headquartered in Seoul, South Korea.

Founded in 1947

samil pharmaceutical co ltd (000520) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

samil pharmaceutical co ltd (000520) Key Developments

Samil Pharmaceutical Co. Ltd., Annual General Meeting, Mar 21, 2014

Samil Pharmaceutical Co. Ltd., Annual General Meeting, Mar 21, 2014., at 10:00 Korea Standard Time. Location: hyoryeong -dong, Seocho-gu. Agenda: To consider the approval of financial statement; to consider the election of Director; to consider the appointment of Audit; to consider the determination of directors' remuneration paid in the ceiling; to consider the determination of audit fees paid in the ceiling; and to consider other references useful for making investment decisions.

Samil Pharmaceutical Co. Ltd Proposes Dividend

Samil Pharmaceutical Co. Ltd. proposed to approve the dividend of KRW 150 per share at the annual general meeting to be held on March 22, 2013.

Samil Pharmaceutical Co. Ltd., Annual General Meeting, Mar 22, 2013

Samil Pharmaceutical Co. Ltd., Annual General Meeting, Mar 22, 2013., at 10:00 Korea Standard Time. Location: dong, Seocho-gu. Agenda: To consider the financial statement; to consider and approval the expected dividend; to consider the incorporation of some changes; to consider the directors remuneration to determine the payment limit; to consider the audit fee limit; to consider the board resolution; and to consider the making investment decisions.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
000520:KS 5,570.00 KRW +40.00

000520 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 000520.
View Industry Companies
 

Industry Analysis

000520

Industry Average

Valuation 000520 Industry Range
Price/Earnings 24.1x
Price/Sales 0.3x
Price/Book 0.4x
Price/Cash Flow 17.2x
TEV/Sales NM Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SAMIL PHARMACEUTICAL CO LTD, please visit www.samil-pharm.co.kr. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.